Home
About
Overview
Sharing Data
ORCID
Help
History (61)
Occupational exposure to nanoparticles at commercial photocopy centers.
Global Dissemination and Implementation of Contemporary Management Principles for Hypertrophic Cardiomyopathy and Role of the International HCM Summit.
Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient.
Meaningful use's benefits and burdens for US family physicians.
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
See All 61 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
Maron BJ, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here? Am J Med. 2020 08; 133(8):886-888.
View in:
PubMed
subject areas
Anti-Arrhythmia Agents
Anticoagulants
Atrial Fibrillation
Cardiomyopathy, Hypertrophic
Catheter Ablation
Death, Sudden, Cardiac
Defibrillators, Implantable
Heart Failure
Humans
Ventricular Outflow Obstruction
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA